Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 12, Issue 6, Pages 447-464
Publisher
Springer Nature
Online
2013-05-31
DOI
10.1038/nrd4010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phosphoramidate ProTide (NUC-1031) and acquired and intrinsic resistance to gemcitabine.
- (2017) C. McGuigan et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells
- (2013) S. E. Pratt et al. CLINICAL CANCER RESEARCH
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
- (2013) Edward J. Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses
- (2012) Wendy Painter et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genotype and Subtype Profiling of PSI-7977 as a Nucleotide Inhibitor of Hepatitis C Virus
- (2012) Angela M. Lam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine
- (2012) Christine L. Clouser et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia
- (2012) Susan O'Brien et al. BRITISH JOURNAL OF HAEMATOLOGY
- In vitro and in vivo studies of pharmacokinetics and antitumor efficacy of D07001-F4, an oral gemcitabine formulation
- (2012) Wei-Hua Hao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Adenosine Transport Blockade Restores Attenuated Cardioprotective Effects of Adenosine Preconditioning in the Isolated Diabetic Rat Heart: Potential Crosstalk with Opioid Receptors
- (2012) Nidhi Krishan Sharma et al. Cardiovascular Toxicology
- HIV-1 Antiretroviral Resistance
- (2012) Michele W. Tang et al. DRUGS
- Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia
- (2012) Tiphaine Adam de Beaumais et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDS
- (2012) Fatih M Uckun et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma
- (2012) Raphaël Maréchal et al. GASTROENTEROLOGY
- Effect of IL28B Genotype on Early Viral Kinetics During Interferon-Free Treatment of Patients With Chronic Hepatitis C
- (2012) Tom W. Chu et al. GASTROENTEROLOGY
- Gemcitabine is active against clinical multiresistant Staphylococcus aureus strains and is synergistic with gentamicin
- (2012) Lars Petter Jordheim et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The HIVdb System for HIV-1 Genotypic Resistance Interpretation
- (2012) Michele W. Tang et al. INTERVIROLOGY
- Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: A randomized, 28-day, dose-ranging trial
- (2012) Maribel Rodriguez-Torres et al. JOURNAL OF HEPATOLOGY
- Fluorocyclopentenyl-cytosine with Broad Spectrum and Potent Antitumor Activity
- (2012) Won Jun Choi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study
- (2012) Hagop Kantarjian et al. LANCET ONCOLOGY
- TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial
- (2012) Takayuki Yoshino et al. LANCET ONCOLOGY
- Elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia
- (2012) Francis Giles et al. LEUKEMIA RESEARCH
- Role of Human Nucleoside Transporters in the Uptake and Cytotoxicity of Azacitidine and Decitabine
- (2012) Vijaya L. Damaraju et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Henipavirus outbreaks to antivirals: the current status of potential therapeutics
- (2012) Christopher C Broder Current Opinion in Virology
- A 40-Year Journey in Search of Selective Antiviral Chemotherapy*
- (2011) Erik De Clercq Annual Review of Pharmacology and Toxicology
- Pharmacokinetics and Safety of FV-100, a Novel Oral Anti-Herpes Zoster Nucleoside Analogue, Administered in Single and Multiple Doses to Healthy Young Adult and Elderly Adult Volunteers
- (2011) Helen S. Pentikis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- INX-08189, a Phosphoramidate Prodrug of 6-O-Methyl-2′-C-Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic and Pharmacodynamic Properties
- (2011) John H. Vernachio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs
- (2011) Ernst-Jan Geutjes et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase I Study of Oral Gemcitabine Prodrug (LY2334737) Alone and in Combination with Erlotinib in Patients with Advanced Solid Tumors
- (2011) Stijn L.W. Koolen et al. CLINICAL CANCER RESEARCH
- Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains
- (2011) A. Doléans-Jordheim et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Gemcitabine-loaded innovative nanocarriers vs GEMZAR: Biodistribution, pharmacokinetic features andin vivoantitumor activity
- (2011) Christian Celia et al. Expert Opinion on Drug Delivery
- Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers
- (2011) Maria Grazia Sarpietro et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126
- (2011) Auke D. Adema et al. INVESTIGATIONAL NEW DRUGS
- First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
- (2011) Eric J. Feldman et al. JOURNAL OF CLINICAL ONCOLOGY
- Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1
- (2011) Woon-Gye Chung et al. JOURNAL OF CONTROLLED RELEASE
- 1237 NO RESISTANCE TO IDX184 WAS DETECTED IN 3-DAY AND 14-DAY CLINICAL STUDIES OF IDX184 IN GENOTYPE 1-INFECTED HCV SUBJECTS
- (2011) J.F. McCarville et al. JOURNAL OF HEPATOLOGY
- 61 ONCE DAILY PSI-7977 PLUS PEGIFN/RBV IN A PHASE 2B TRIAL: RAPID VIROLOGIC SUPPRESSION IN TREATMENT-NAIVE PATIENTS WITH HCV GT2/GT3
- (2011) J. Lalezari et al. JOURNAL OF HEPATOLOGY
- In Vitro-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs
- (2011) G. Andrei et al. JOURNAL OF VIROLOGY
- Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition
- (2011) Pedro Cano-Soldado et al. MEDICINAL RESEARCH REVIEWS
- Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer
- (2011) Soukaina Réjiba et al. Nanomedicine-Nanotechnology Biology and Medicine
- Integrating pharmacogenetics into gemcitabine dosing—time for a change?
- (2011) Joseph Ciccolini et al. Nature Reviews Clinical Oncology
- A Conjugate of Gemcitabine With Bisphosphonate (Gem/BP) Shows Potential as a Targeted Bone-Specific Therapeutic Agent in an Animal Model of Human Breast Cancer Bone Metastases
- (2011) A. A. El-Mabhouh et al. ONCOLOGY RESEARCH
- Drug uptake transporters in antiretroviral therapy
- (2011) Gerard Minuesa et al. PHARMACOLOGY & THERAPEUTICS
- Analysis of the Ex Vivo and In Vivo Antiretroviral Activity of Gemcitabine
- (2011) Christine L. Clouser et al. PLoS One
- Progress in the development of new therapies for herpesvirus infections
- (2011) Nathan B Price et al. Current Opinion in Virology
- Development of Hexadecyloxypropyl Tenofovir (CMX157) for Treatment of Infection Caused by Wild-Type and Nucleoside/Nucleotide-Resistant HIV
- (2010) E. R. Lanier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cytomegalovirus UL97 Mutations Affecting Cyclopropavir and Ganciclovir Susceptibility
- (2010) Sunwen Chou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Superior Preclinical Efficacy of Gemcitabine Developed As Chitosan Nanoparticulate System
- (2010) José L. Arias et al. BIOMACROMOLECULES
- Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma
- (2010) Raphaël Maréchal et al. CANCER
- Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma
- (2010) N. Gokbuget et al. HAEMATOLOGICA
- Improved plasma stability and sustained release profile of gemcitabine via polypeptide conjugation
- (2010) Lik-Voon Kiew et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
- (2010) Andries M. Bergman et al. INVESTIGATIONAL NEW DRUGS
- Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come
- (2010) L. T. Ford et al. JOURNAL OF CLINICAL PATHOLOGY
- Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: An original drug delivery pathway
- (2010) L. Bildstein et al. JOURNAL OF CONTROLLED RELEASE
- RG7128 Alone or in Combination with Pegylated Interferon‐α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV‐Infected Patients
- (2010) Sophie Le Pogam et al. JOURNAL OF INFECTIOUS DISEASES
- Improved Syntheses of 5′-S-(2-Aminoethyl)-6-N-(4-nitrobenzyl)-5′-thioadenosine (SAENTA), Analogues, and Fluorescent Probe Conjugates: Analysis of Cell-Surface Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels for Prediction of the Antitumor Efficacy of Gemcitabine
- (2010) Morris J. Robins et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
- (2010) Edward J Gane et al. LANCET
- The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
- (2010) Lars Petter Jordheim et al. LANCET ONCOLOGY
- Nucleoside analog ARC targets Mcl-1 to induce apoptosis in leukemia cells
- (2010) U G Bhat et al. LEUKEMIA
- 8-Amino-Adenosine Inhibits Multiple Mechanisms of Transcription
- (2010) J. A. Frey et al. MOLECULAR CANCER THERAPEUTICS
- Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy
- (2010) B. Brueckner et al. MOLECULAR CANCER THERAPEUTICS
- Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2
- (2010) Olaf H. Temmink et al. MOLECULAR CANCER THERAPEUTICS
- S110, a 5-Aza-2'-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
- (2010) J. C. Chuang et al. MOLECULAR CANCER THERAPEUTICS
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- Massively parallel pyrosequencing in HIV research
- (2009) Frederic D Bushman et al. AIDS
- Retention of Metabolites of 2',3'-Didehydro-3'-Deoxy-4'-Ethynylthymidine, a Novel Anti-Human Immunodeficiency Virus Type 1 Thymidine Analog, in Cells
- (2009) X. Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Special feature of mixed phosphotriester derivatives of cytarabine
- (2009) Marie-Hélène Gouy et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels
- (2009) Christine M. Stellrecht et al. BREAST CANCER RESEARCH AND TREATMENT
- Assessment of GS-9219 in a Pet Dog Model of Non-Hodgkin's Lymphoma
- (2009) D. M. Vail et al. CLINICAL CANCER RESEARCH
- Targeting DNA Repair in Chronic Lymphocytic Leukemia Cells with a Novel Acyclic Nucleotide Analogue, GS-9219
- (2009) C.-Y. Tsai et al. CLINICAL CANCER RESEARCH
- Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma
- (2009) R. Marechal et al. CLINICAL CANCER RESEARCH
- Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
- (2009) Fabien Zoulim et al. GASTROENTEROLOGY
- Resistance profile of the new nucleoside reverse transcriptase inhibitor apricitabine
- (2009) P. Cahn et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies
- (2009) Joseph Ciccolini et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Clinical and Pharmacokinetic Study of Oral Sapacitabine in Patients With Acute Leukemia and Myelodysplastic Syndrome
- (2009) Hagop Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine
- (2009) David M. Bender et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anticancer Efficacy of Squalenoyl Gemcitabine Nanomedicine on 60 Human Tumor Cell Panel and on Experimental Tumor
- (2009) L. Harivardhan Reddy et al. MOLECULAR PHARMACEUTICS
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Molecular strategies to inhibit the replication of RNA viruses
- (2008) Pieter Leyssen et al. ANTIVIRAL RESEARCH
- Inhibition of topoisomerase II by 8-chloro-adenosine triphosphate induces DNA double-stranded breaks in 8-chloro-adenosine-exposed human myelocytic leukemia K562 cells
- (2008) Sheng-Yong Yang et al. BIOCHEMICAL PHARMACOLOGY
- CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell lines
- (2008) Carlos M. Galmarini et al. BRITISH JOURNAL OF HAEMATOLOGY
- Oral Administration of Gemcitabine in Patients with Refractory Tumors: A Clinical and Pharmacologic Study
- (2008) S. A. Veltkamp et al. CLINICAL CANCER RESEARCH
- 188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases
- (2008) Amal A. El-Mabhouh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients
- (2008) Akira Horikoshi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Antitumoral activity of PEG–gemcitabine prodrugs targeted by folic acid
- (2008) Gianfranco Pasut et al. JOURNAL OF CONTROLLED RELEASE
- 588 IN VITRO ANTIVIRAL ACTIVITY AND PHARMACOLOGY OF IDX184, A NOVEL AND POTENT INHIBITOR OF HCV REPLICATION
- (2008) E. Cretton-Scott et al. JOURNAL OF HEPATOLOGY
- Pradefovir: A Prodrug That Targets Adefovir to the Liver for the Treatment of Hepatitis B
- (2008) K. Raja Reddy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Activation ofp16Gene Silenced by DNA Methylation in Cancer Cells by Phosphoramidate Derivatives of 2′-Deoxyzebularine
- (2008) Christine B. Yoo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Use of Massively Parallel Ultradeep Pyrosequencing To Characterize the Genetic Diversity of Hepatitis B Virus in Drug-Resistant and Drug-Naive Patients and To Detect Minor Variants in Reverse Transcriptase and Hepatitis B S Antigen
- (2008) M. Solmone et al. JOURNAL OF VIROLOGY
- Nucleoside analogs: molecular mechanisms signaling cell death
- (2008) B Ewald et al. ONCOGENE
- Discovery of New Hexagonal Supramolecular Nanostructures Formed by Squalenoylation of an Anticancer Nucleoside Analogue
- (2008) Patrick Couvreur et al. Small
- Liposomal Coencapsulated Fludarabine and Mitoxantrone for Lymphoproliferative Disorder Treatment**Xiaobin Zhao and Jianmei Wu contributed equally to this study.
- (2007) Xiaobin Zhao et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now